The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ruff Shamim since 2016.
This trader's CIK number is 1685986.
At the time of last reporting, Ruff Shamim was the Director of Reata Pharmaceuticals Inc. (stock ticker symbol RETA).
Also see all insider trading activities at Reata Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | SRPT | 0 | $0 | 0 | $0 | 6,932 | $50,175 |
| 2017 | SRPT | 0 | $0 | 33,638 | $1,646,572 | 42,503 | $487,402 |
| 2016 | SRPT | 0 | $0 | 7,311 | $438,660 | 8,311 | $127,862 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RETA | 0 | $0 | 13,975 | $1,835,498 | 13,975 | $944,554 |
1. Sarepta Therapeutics, Inc. (SRPT)
2. Reata Pharmaceuticals Inc (RETA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-22 | SRPT | Option Ex | 4,432 | .00 | 0 |
| 2018-03-15 | SRPT | Option Ex | 2,500 | 20.07 | 50,175 |
| 2017-11-06 | SRPT | Sale | 10,000 | 55.00 | 550,000 |
| 2017-11-06 | SRPT | Option Ex | 10,000 | 14.76 | 147,600 |
| 2017-10-03 | SRPT | Option Ex | 11,500 | 14.76 | 169,740 |
| 2017-10-03 | SRPT | Sale | 11,500 | 50.00 | 575,000 |
| 2017-08-03 | SRPT | Option Ex | 8,865 | .00 | 0 |
| 2017-07-20 | SRPT | Option Ex | 6,250 | 13.71 | 85,687 |
| 2017-07-21 | SRPT | Option Ex | 5,888 | 14.33 | 84,375 |
| 2017-07-20 | SRPT | Sale | 6,250 | 42.00 | 262,500 |
| 2017-07-21 | SRPT | Sale | 5,888 | 44.00 | 259,072 |
| 2016-11-08 | SRPT | Option Ex | 1,000 | 26.24 | 26,240 |
| 2016-09-22 | SRPT | Option Ex | 7,311 | 13.90 | 101,622 |
| 2016-09-22 | SRPT | Sale | 7,311 | 60.00 | 438,660 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-28 | RETA | Sale | 8,235 | 164.53 | 1,354,888 |
| 2023-07-28 | RETA | Option Ex | 8,235 | 92.20 | 759,267 |
| 2023-03-10 | RETA | Option Ex | 5,740 | 32.28 | 185,287 |
| 2023-03-10 | RETA | Sale | 5,740 | 83.73 | 480,610 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ruff Shamim (Director of Reata Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.